|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | GIP ELISA Assay | Amyloid Beta (N3pE) ELISA Assay | CA 242 ELISA Assay | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Mac-2 binding protein (Mac-2bp) ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27203 | 27716 | 101-85 | 27600 | 27362 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of human total GIP in EDTA-plasma and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Amyloid ß (N3pE-42) in brain tissue extract. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of CA 242 cancer antigen in serum. For research use only, not for use in diagnostic procedures. Please note this assay has a 5 kit purchase minimum. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Solid phase sandwich ELISA for the determination of human Mac-2bp in serum, EDTA-plasma and cell culture media. For research use only, not for use in diagnostic procedures. |
| Detection Target | ANGPTL2 | Anti-Trastuzumab (Herceptin®) | Complement Factor P (Properdin) | Metanephrine / Normetanephrine | Anti-Adalimumab (Humira®) |
| Sample Type | Serum, Blood Plasma, Cell Culture Supernatant | Serum and plasma. | Human serum or EDTA plasma. | Urine | Serum and plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1.88 to 120 pmol/L | 7.75 to 496 pg/mL | 15 to 150 U/mL | 1.56 to 100.0 ng/mL | 0.78 to 100 ng/mL |
| Sensitivity | 0.01 ng/mL | 30 ng/mL | Inquire | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 5 ng/mL |
| Assay Time | 2 hrs (incubation) | Overnight + 1 hr 30 mins (incubation) | 3 hrs 30 mins (incubation) | 2 hours (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |